| INOVIO PHARMACEUTICAL INC |
| USA |
| Gesundheit |
| US45773H4092 / A400EJ |
| GBM (Frankfurt) / INO (NASDAQ) |
| FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO |
| - |
| https://inovio.com/ |
|
Inovio Pharmaceuticals, Inc. is a biotechnology co..
>Volltext.. |
| 113.1 Mio. EUR |
| 81.68 Mio. EUR |
| 0.16 Mio. EUR |
| -79.98 Mio. EUR |
| -75.62 Mio. EUR |
| -2.25 EUR |
| 9.18 Mio. EUR |
| 20.98 Mio. EUR |
| -81.68 Mio. EUR |
| 1.5 |
| -71.99% |
| 34.4% |
| - |
| - |
| - |
| - |
| INOVIO |
| 22.10.25 |
|